Here, we showed for the first time that ERRα can transactivate the T:E fusion gene via its direct binding to TMPRSS2 promoter/enhancer in both AR-positive and -negative prostate cancer cells, with further potentiation by its coregulator PGC-1α. The gene discussed is ESRRA; the disease is prostate carcinoma.